Robert Steinbrugger has extensive experience in the pharmaceutical and biotechnology industries, currently serving as the Leiter Wirkstoffproduktion Lactulose and a member of the Leitungsteam Wirkstoffproduktion Lactulose at Fresenius Kabi since May 2018. Prior to this role, Robert held positions as QA Manager in Novartis Technical Operations - Aseptics from September 2016 to April 2018, and as QA Manager Microbiology at Sandoz from May 2013 to August 2016. Earlier in the career, Robert worked at ProtAffin Biotechnologie AG, starting as an R&D Assistant in the Manufacturing Department before becoming Production Line Responsible for QA/QC Microbiology. Robert Steinbrugger holds a degree in Biochemistry and Molecular Biology from the University of Graz.